These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11188005)

  • 21. Respiratory mechanics before and after late artificial surfactant rescue.
    Todd DA; Choukroun ML; Fayon M; Kays C; Guénard H; Galpérine I; Demarquez JL
    J Paediatr Child Health; 1995 Dec; 31(6):532-6. PubMed ID: 8924306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
    Malathi I; Ng KC
    Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OSIRIS trial.
    Tarnow-Mordi W
    Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
    [No Abstract]   [Full Text] [Related]  

  • 25. On surfactant replacement therapy with Exosurf.
    Courtney SE
    Pediatr Pulmonol; 1992 May; 13(1):60-1. PubMed ID: 1589317
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral blood flow velocity after surfactant instillation in preterm infants.
    van de Bor M; Ma EJ; Walther FJ
    J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962
    [No Abstract]   [Full Text] [Related]  

  • 27. Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
    McMillan DD; Singhal N; Shukla AK; Schürch S
    Pediatr Pulmonol; 1998 Sep; 26(3):173-82. PubMed ID: 9773912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosurf versus Survanta surfactant preparations: proportional-hazards regression analysis of time to successful extubation and discontinuation of oxygen therapy.
    Arnold C; Adams E; Torres E; Sidebottom R
    J Perinatol; 1996; 16(1):9-14. PubMed ID: 8869533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1990 Oct; 264(14):1802. PubMed ID: 2169534
    [No Abstract]   [Full Text] [Related]  

  • 30. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
    Frey B; Keller E; Losa M
    Eur J Pediatr; 1999 Jul; 158(7):610. PubMed ID: 10412829
    [No Abstract]   [Full Text] [Related]  

  • 32. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
    Wyble L; Santeiro ML
    Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726
    [No Abstract]   [Full Text] [Related]  

  • 33. Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
    Bose C; Corbet A; Bose G; Prats JG; Russell L; Edwards K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S13-7. PubMed ID: 1735845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse experiences in an Exosurf treated group.
    Chatfield SL; Kelly EJ; Dear PR
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F78. PubMed ID: 8117137
    [No Abstract]   [Full Text] [Related]  

  • 35. Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
    Doig C
    JAMA; 1995 Apr; 273(16):1259-60. PubMed ID: 7715036
    [No Abstract]   [Full Text] [Related]  

  • 36. Surfactant trials.
    Moya FR; Sinha SK; D'Agostino R
    Pediatrics; 2006 Jan; 117(1):245-7; author reply 247-8. PubMed ID: 16396889
    [No Abstract]   [Full Text] [Related]  

  • 37. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
    Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
    Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
    Helbich TH; Popow C; Dobner M; Wunderbaldinger P; Zekert M; Herold CJ
    Eur J Radiol; 1998 Oct; 28(3):243-9. PubMed ID: 9881260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial examining cerebral haemodynamics following artificial or animal surfactant.
    Murdoch E; Kempley ST
    Acta Paediatr; 1998 Apr; 87(4):411-5. PubMed ID: 9628297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
    Pfenninger J; Aebi C; Bachmann D; Wagner BP
    Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.